Vitamin D metabolic pathway

The Vitamin D metabolic pathway is a multi-step endocrine process essential for maintaining systemic calcium and phosphate homeostasis and ensuring proper bone mineralization (NIH Office of Dietary Supplements, 2023). The pathway begins with the synthesis of Vitamin D3 in the skin via UV radiation or dietary intake, followed by two successive hydroxylation steps: first in the liver by enzymes such as CYP2R1 to form 25-hydroxyvitamin D, and then primarily in the kidneys by CYP27B1 to produce the active hormone, 1,25-dihydroxyvitamin D, also known as calcitriol (StatPearls, 2023). Calcitriol exerts its biological effects by binding to the Vitamin D Receptor (VDR), a nuclear transcription factor that regulates the expression of genes involved in intestinal calcium absorption and bone remodeling (UniProt, P11473). Beyond mineral metabolism, the pathway plays significant roles in immune modulation, cell differentiation, and the suppression of parathyroid hormone secretion (Journal of Clinical Investigation, 2006). Clinical disorders associated with pathway dysfunction include rickets, osteomalacia, and secondary hyperparathyroidism in chronic kidney disease (Mayo Clinic, 2023). Therapeutic strategies focus on VDR activation using calcitriol or its analogs, as well as supplementation with Vitamin D precursors to correct deficiencies (PubChem, 2024). Monitoring the pathway's efficacy and safety typically involves measuring serum levels of 25-hydroxyvitamin D and monitoring for potential hypercalcemia (NIH, 2023).

Other names

Vitamin D endocrine systemVitamin D metabolismVitamin D signaling pathwayVitamin D activation pathway

Drugs targeting this pathway primarily act as agonists of the Vitamin D Receptor (VDR) to modulate gene transcription, or serve as exogenous substrates (precursors) to increase the production of active Vitamin D metabolites like 1,25-dihydroxyvitamin D (StatPearls, 2023).